Cargando…
Safety Evaluation of α-Lipoic Acid Supplementation: A Systematic Review and Meta-Analysis of Randomized Placebo-Controlled Clinical Studies
Alpha-lipoic acid (ALA) is a natural short-chain fatty acid that has attracted great attention in recent years as an antioxidant molecule. However, some concerns have been recently raised regarding its safety profile. To address the issue, we aimed to assess ALA safety profile through a systematic r...
Autores principales: | Fogacci, Federica, Rizzo, Manfredi, Krogager, Christoffer, Kennedy, Cormac, Georges, Coralie M.G., Knežević, Tamara, Liberopoulos, Evangelos, Vallée, Alexandre, Pérez-Martínez, Pablo, Wenstedt, Eliane F.E., Šatrauskienė, Agnė, Vrablík, Michal, Cicero, Arrigo F.G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7603186/ https://www.ncbi.nlm.nih.gov/pubmed/33086555 http://dx.doi.org/10.3390/antiox9101011 |
Ejemplares similares
-
Efficacy and Safety of Armolipid Plus(®): An Updated PRISMA Compliant Systematic Review and Meta-Analysis of Randomized Controlled Clinical Trials
por: Cicero, Arrigo F. G., et al.
Publicado: (2021) -
Metabolic effect of berberine–silymarin association: A meta‐analysis of randomized, double‐blind, placebo‐controlled clinical trials
por: Fogacci, Federica, et al.
Publicado: (2019) -
Nutraceuticals and Hypertensive Disorders in Pregnancy: The Available Clinical Evidence
por: Fogacci, Silvia, et al.
Publicado: (2020) -
The year in nutrition medicine 2023
por: Cicero, Arrigo F.G., et al.
Publicado: (2023) -
Nutraceuticals in the Management of Dyslipidemia: Which, When, and for Whom? Could Nutraceuticals Help Low-Risk Individuals with Non-optimal Lipid Levels?
por: Cicero, Arrigo F. G., et al.
Publicado: (2021)